0

524202

LACTOSE

img img img img
No Data Available

LACTOSE (INDIA) LTD. Share Price Update

As of the latest trading session, LACTOSE (INDIA) LTD. is trading at ₹115.8, down by ₹-5.34 or -4.40% from its previous close. The stock has moved between ₹115.00 and ₹120.95 today. Over the past year, the stock has delivered a return of 21.88%. In the last month, it has returned 2.08%.

Investment Returns

Over 1 Month 2.08% Over 3 Months 24.69% Over 6 Months -4.11% Over 1 Year 21.88%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

LACTOSE (INDIA) LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 145.40
  • P/E Ratio (TTM) 25.13
  • Beta 0.73
  • Book Value / share 51.46
  • Return on equity 9.75%
  • EPS (TTM) 4.82
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 1.88
info icon alternate text

LACTOSE (INDIA) LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 45.77
Operating Expense 43.67
Net Profit 1.88
Net Profit Margin (%) 4.10
Earnings Per Share (EPS) 1.49
EBITDA 5.24
Effective Tax Rate (%) 18.61
Particulars DEC 2025 (Values in Cr)
Revenue 36.77
Operating Expense 36.52
Net Profit 0.53
Net Profit Margin (%) 1.44
Earnings Per Share (EPS) 0.42
EBITDA 3.70
Effective Tax Rate (%) 39.77
Particulars SEP 2025 (Values in Cr)
Revenue 41.18
Operating Expense 38.41
Net Profit 2.16
Net Profit Margin (%) 5.24
Earnings Per Share (EPS) 1.71
EBITDA 5.61
Effective Tax Rate (%) 31.52
Particulars JUN 2025 (Values in Cr)
Revenue 39.58
Operating Expense 37.69
Net Profit 1.50
Net Profit Margin (%) 3.78
Earnings Per Share (EPS) 1.19
EBITDA 4.88
Effective Tax Rate (%) 34.49
Particulars MAR 2025 (Values in Cr)
Revenue 27.77
Operating Expense 27.60
Net Profit 0.64
Net Profit Margin (%) 2.30
Earnings Per Share (EPS) 0.51
EBITDA 3.78
Effective Tax Rate (%) -16.36
Particulars MAR 2026 (Values in Cr)
Revenue 163.29
Operating Expense 155.75
Net Profit 6.06
Net Profit Margin (%) 3.71
Earnings Per Share (EPS) 4.82
EBITDA 19.45
Effective Tax Rate (%) 29.69
Particulars MAR 2025 (Values in Cr)
Revenue 116.40
Operating Expense 110.92
Net Profit 5.16
Net Profit Margin (%) 4.43
Earnings Per Share (EPS) 4.10
EBITDA 18.41
Effective Tax Rate (%) 25.28
Particulars MAR 2024 (Values in Cr)
Revenue 113.89
Operating Expense 105.35
Net Profit 6.79
Net Profit Margin (%) 5.96
Earnings Per Share (EPS) 5.39
EBITDA 20.13
Effective Tax Rate (%) 29.81
Particulars MAR 2023 (Values in Cr)
Revenue 65.80
Operating Expense 65.05
Net Profit 1.21
Net Profit Margin (%) 1.83
Earnings Per Share (EPS) 0.96
EBITDA 12.10
Effective Tax Rate (%) 17.80
Particulars MAR 2022 (Values in Cr)
Revenue 45.94
Operating Expense 43.36
Net Profit 2.45
Net Profit Margin (%) 5.33
Earnings Per Share (EPS) 2.10
EBITDA 12.84
Effective Tax Rate (%) 22.71
Particulars MAR 2025 (Values in Cr)
Book Value / Share 41.48
ROE % 9.75
ROCE % 12.69
Total Debt to Total Equity 0.91
EBITDA Margin 15.82
Particulars MAR 2024 (Values in Cr)
Book Value / Share 37.41
ROE % 15.49
ROCE % 17.79
Total Debt to Total Equity 0.89
EBITDA Margin 17.67
Particulars MAR 2023 (Values in Cr)
Book Value / Share 32.22
ROE % 3.03
ROCE % 9.19
Total Debt to Total Equity 1.00
EBITDA Margin 18.39
Particulars MAR 2022 (Values in Cr)
Book Value / Share 31.21
ROE % 6.59
ROCE % 10.09
Total Debt to Total Equity 1.18
EBITDA Margin 27.97
Particulars MAR 2021 (Values in Cr)
Book Value / Share 30.15
ROE % -7.15
ROCE % 2.75
Total Debt to Total Equity 1.23
EBITDA Margin 18.71
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 4.93
Total Assets 133.46
Total Liabilities 133.46
Total Equity 58.73
Share Outstanding 1
Price to Book Ratio 2.14
Return on Assets (%) 3.86
Return on Capital (%) 4.49
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.85
Total Assets 100.73
Total Liabilities 100.73
Total Equity 47.09
Share Outstanding 1
Price to Book Ratio 3.73
Return on Assets (%) 6.73
Return on Capital (%) 7.97
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.91
Total Assets 101.29
Total Liabilities 101.29
Total Equity 40.56
Share Outstanding 1
Price to Book Ratio 1.36
Return on Assets (%) 1.19
Return on Capital (%) 1.53
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.07
Total Assets 90.22
Total Liabilities 90.22
Total Equity 39.28
Share Outstanding 1
Price to Book Ratio 1.92
Return on Assets (%) 2.71
Return on Capital (%) 3.05
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 2.66
Total Assets 88.34
Total Liabilities 88.34
Total Equity 35.08
Share Outstanding 1
Price to Book Ratio 0.89
Return on Assets (%) -2.80
Return on Capital (%) -3.07
Particulars MAR 2025 (Values in Cr)
Net Income 6.91
Cash from Operations 0.83
Cash from Investing -15.56
Cash from Financing 18.81
Net change in Cash 2.95
Free Cash Flow 15.21
Particulars MAR 2024 (Values in Cr)
Net Income 9.66
Cash from Operations 9.51
Cash from Investing -2.07
Cash from Financing -5.71
Net change in Cash 0.94
Free Cash Flow 11.70
Particulars MAR 2023 (Values in Cr)
Net Income 1.46
Cash from Operations 7.93
Cash from Investing -0.91
Cash from Financing -8.31
Net change in Cash -1.34
Free Cash Flow 9.49
Particulars MAR 2022 (Values in Cr)
Net Income 3.16
Cash from Operations 8.39
Cash from Investing -0.56
Cash from Financing -8.14
Net change in Cash -0.23
Free Cash Flow 9.72
Particulars MAR 2021 (Values in Cr)
Net Income -3.27
Cash from Operations 2.13
Cash from Investing -6.17
Cash from Financing 4.52
Net change in Cash 0.51
Free Cash Flow 7.62
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 32.16 13.67 1.55 246.45 23.12 40.00
BLISS GVS PHARMA LTD 317.60 24.29 2.81 3359.86 118.35 329.45
CIPLA LTD 1413.50 27.70 3.31 114182.61 1165.55 1672.20
FERMENTA BIOTECH LTD. 302.00 10.07 2.27 888.82 256.40 399.00
GLAXOSMITHKLINE PHARMACEUTICAL 2300.10 38.33 17.18 38965.08 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 32.16 22.49 4.14 246.45 23.12 40.00
AMRUTANJAN HEALTH CARE LTD. 560.60 25.13 4.37 1620.73 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8795.40 105.70 27.52 21988.50 7630.00 10653.05
BLISS GVS PHARMA LTD 317.60 34.15 2.90 3359.86 118.35 329.45

LACTOSE (INDIA) LTD. shareholding pattern

Holding
45.73%
53.64%
0.61%
26.07%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

LACTOSE (INDIA) LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
115.50 -4.66 redarrow
red-green-graph indicator
7 Bearish
9 Bullish
  • 5 Days 121.20
  • 26 Days 112.90
  • 10 Days 119.10
  • 50 Days 107.40
  • 12 Days 118.30
  • 100 Days 105.00
  • 20 Days 115.10
  • 200 Days 108.90
120.53 PIVOT
First Support 116.07 First Resistance 125.62 Second Support 110.98 Second Resistance 130.08 Third Support 106.52 Third Resistance 135.17
RSI 58.44 ADX 52.12 MACD 5.41 Williams % R -45.00 Commodity Channel Index (CCI) 65.68
Date 2026-05-25 Week 11318.00 Same Day 8096.00 Month 7377.00
1 Year 0.73 3 Year 0.59
Over 1 Month
2.08% down
Over 1 Year
21.88% down
Over 3 Months
24.69% down
Over 3 Years
37.71% down
Over 6 Months
-4.11% down
Over 5 Years
32.64% down

LACTOSE (INDIA) LTD. Corporate Actions

Top Gainers

Top Losers

LACTOSE (INDIA) LTD. Share Price

Lactose (India) Limited was incorporated on March 1991 as a Public Limited Company in Vadodara district of Gujarat. Company engages in the manufacturing and trading of pharmaceutical products. It edible and pharmaceutical grade lactose, as an ingredient used in pharmaceutical products, as well as in dairy, food, confectionery, and beverage industries. It also manufactures dairy whitener, dairy calcium, whey powder, casein, caseinate, butter, and ghee. Further, it engage in the contract manufacture of pharmaceutical products.

The company is having their manufacturing facilities located at Vadodara in Gujarat. This state of art manufacturing facilities for the manufacture of pharmaceutical formulations is in compliance with all international standards. The manufacturing facilities include wet granulation, Fluid bed drying, compaction, blending and coating facilities with the latest technology equipments. The company is well backed up by its excellent network of indenting agents in India i.e. Mumbai, Delhi, Chennai, Bangalore, Calcutta, Hyderabad and Ahmedabad.

The company set up a project to manufacture lactose IP/BP grade, an import substitute, with an installed capacity of 465 TPA at an estimated cost of Rs 4.5 crore. The unit was commissioned by Alfa Laval, Pune, a subsidiary of Alfa Laval, Sweden. In January 1994, the company commenced commercial production of Lactose.

In the year 1994, the company undertook an expansion and forward integration programme involving the capacity expansion of lactose from 465 tpa to 1500 tpa. They also set up of a pharmaceutical formulation plant with three sections, namely capsule section, tablet section and indictable section.

During the year 1995-96, the company started processing sweetened condenced milk for domestic supply and acid casein for exports. They had started the job work of condensed milk casein powder.

During the year 2004-05, the company streamlined their pharmaceutical plant and entered into long-term contract manufacturing for one of the leading multinational company. They invested substantially in upgrading and renovating the Pharmaceutical facilities as per the requirement of the new Schedule M, as per the directives from the Food and Drug Administration. Also, they started a new equipment manufacture, assemble and export for Projects division in Kandla SEZ (Special Economic Zone).

During the year 2006-07, the company undertook major expansion programme at their existing production site for manufacturing of value added product 'LACTULOSE' which is a forward integration of their existing product 'LACTOSE'.

During the year 2007-08, the company successfully implemented the task undertaken last year and commissioned the new liquid orals division. During the year 2008-09, the company started manufacturing of Liquid Formulations.

The Company in 2010, formed strategic alliance with Kerry Group of Ireland for contract manufacturing Of lactose 10,000 Mt / Annum.

It started manufacturing for Dr Reddy's for their Liquid Oral Bottles in 2015. In 2016, it started Lactulose Manufacturing API Plant. In 2022, it started own marketing & sales of Lactose Monohydrate under the banner of Lactose (India) Limited.

The Company in 2023, launched production of Lactulose with state of art manufacturing facility. The Plant produces Lactulose Concentrate USP & Lactulose Solution USP/EP. It broadened the horizons by getting into contract manufacturing of Tablets, Liquid orals & Manufacturing of Finished Formulations.

Parent organization Toshniwal
NSE symbol [-]
Founded 1991
stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Lactose (India) Ltd?

Answer Field

Lactose (India) Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 115.50 as on May 26 2026 03:29 PM.

What is the Market Cap of Lactose (India) Ltd Share?

Answer Field

The market cap of Lactose (India) Ltd for NSE ₹ 0.00 & for BSE ₹ 145.40 as on May 26 2026 03:29 PM.

What is the 52 Week High and Low of Lactose (India) Ltd?

Answer Field

The 52 Week High and Low of Lactose (India) Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 136.70 and ₹ 76.01.

What is 1 year return for Lactose (India) Ltd?

Answer Field

The 1 year returns on the stock has been 21.88%.

What is the P/E Ratio of Lactose (India) Ltd Share?

Answer Field

As on May 26 2026 03:29 PM the price-to-earnings (PE) ratio for Lactose (India) Ltd share is 25.13.

What is the PB ratio of Lactose (India) Ltd Share?

Answer Field

As on May 26 2026 03:29 PM, the price-to-book (PB) ratio for Lactose (India) Ltd share is 51.46.

How to Buy Lactose (India) Ltd Share?

Answer Field

You can trade in Lactose (India) Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Lactose (India) Ltd Share on Bajaj Broking App?

Answer Field

To buy Lactose (India) Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Lactose (India) Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|